trending Market Intelligence /marketintelligence/en/news-insights/trending/VEykR32T3la9P9uSXhnVDA2 content
Log in to other products

Login to Market Intelligence Platform

 /


Looking for more?

Contact Us

Request a Demo

You're one step closer to unlocking our suite of comprehensive and robust tools.

Fill out the form so we can connect you to the right person.

If your company has a current subscription with S&P Global Market Intelligence, you can register as a new user for access to the platform(s) covered by your license at Market Intelligence platform or S&P Capital IQ.

  • First Name*
  • Last Name*
  • Business Email *
  • Phone *
  • Company Name *
  • City *
  • We generated a verification code for you

  • Enter verification Code here*

* Required

In This List

Irras initiates voluntary recall of brain medical device due to battery defect

Gauging Supply Chain Risk In Volatile Times

S&P Global Market Intelligence

Cannabis: Hashing Out a Budding Industry

Segment

IFRS 9 Impairment How It Impacts Your Corporation And How We Can Help

The Market Intelligence Platform


Irras initiates voluntary recall of brain medical device due to battery defect

Stockholm-based Irras AB initiated a voluntary recall of its IRRAflow device due to battery defect.

IRRAflow is a closed-circuit medical device for treating acute bleeding inside the skull or brain.

According to Irras, during a demonstration one unit's battery overheated while charging on standby mode, an incident that the company believes is an isolated case of manufacturing failure.

The company has also stopped selling the device and started the replacement process for the affected control units.

Irras noted that despite the effects of the recall on 2017 sales of the device, its goal of exceeding sales of 250 million Swedish kronor for 2020 still remains.

Irras makes medical equipment for a range of brain pathologies in Sweden and internationally.

As of Dec. 12, US$1 was equivalent to 8.44 Swedish kronor.